C3 and neurodegenerative disease: Accumulating evidence shows that complement C3 is present in patients of all major neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis [6-9].